Trials / Conditions / Transplant-Related Hematologic Malignancy
Transplant-Related Hematologic Malignancy
6 registered clinical trials studyying Transplant-Related Hematologic Malignancy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | GM-CSF With Post-Transplant Cyclophosphamide NCT04237623 | Northside Hospital, Inc. | Phase 2 |
| Active Not Recruiting | Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant NCT03131934 | University College, London | EARLY_Phase 1 |
| Completed | Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic NCT03434704 | Ciceri Fabio | Phase 2 |
| Terminated | Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT NCT03963024 | IRCCS San Raffaele | Phase 1 |
| Withdrawn | Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo- NCT01751243 | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Phase 1 |
| Completed | Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant NCT03961919 | Ciceri Fabio | Phase 2 |